Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jan 26;1(1):5.
doi: 10.1186/2047-2994-1-5.

National Institute of Allergy and Infectious Disease (NIAID) Funding for Studies of Hospital-Associated Bacterial Pathogens: Are Funds Proportionate to Burden of Disease?

Seunghyug Kwon  1 , Marin L Schweizer, Eli N Perencevich
Affiliations

National Institute of Allergy and Infectious Disease (NIAID) Funding for Studies of Hospital-Associated Bacterial Pathogens: Are Funds Proportionate to Burden of Disease?

Seunghyug Kwon et al. Antimicrob Resist Infect Control. .

Abstract

Background: Hospital-associated infections (HAIs) are associated with a considerable burden of disease and direct costs greater than $17 billion. The pathogens that cause the majority of serious HAIs are Enterococcus faecium, Staphylococcus aureus, Clostridium difficile, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species, referred as ESCKAPE. We aimed to determine the amount of funding the National Institute of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) allocates to research on antimicrobial resistant pathogens, particularly ESCKAPE pathogens.

Methods: The NIH Research Portfolio Online Reporting Tools (RePORT) database was used to identify NIAID antimicrobial resistance research grants funded in 2007-2009 using the terms "antibiotic resistance," "antimicrobial resistance," and "hospital-associated infection."

Results: Funding for antimicrobial resistance grants has increased from 2007-2009. Antimicrobial resistance funding for bacterial pathogens has seen a smaller increase than non-bacterial pathogens. The total funding for all ESKCAPE pathogens was $ 22,005,943 in 2007, $ 30,810,153 in 2008 and $ 49,801,227 in 2009. S. aureus grants received $ 29,193,264 in FY2009, the highest funding amount of all the ESCKAPE pathogens. Based on 2009 funding data, approximately $1,565 of research money was spent per S. aureus related death and $750 of was spent per C. difficile related death.

Conclusions: Although the funding for ESCKAPE pathogens has increased from 2007 to 2009, funding levels for antimicrobial resistant bacteria-related grants is still lower than funding for antimicrobial resistant non-bacterial pathogens. Efforts may be needed to improve research funding for resistant-bacterial pathogens, particularly as their clinical burden increases.

PubMed Disclaimer

Figures

Figure 1
Figure 1
NIAID Funding for Antimicrobial Resistance Stratified by Non-bacterial Grants vs. Bacterial Grants.
Figure 2
Figure 2
NIAID Funding by ESCKAPE Pathogen.
Figure 3
Figure 3
Funding from NIH Research, Condition, and Disease Categories Category "Antimicrobial Resistance" (FY2008 and FY2009).
See this image and copyright information in PMC

References

    1. Istook E. Research funding on major diseases is not proportionate to taxpayers' needs. J NIH Res. 1997;9(8):26–8.
    1. Anderson C. NIH budget: A new kind of earmarking. Science. 1993;260(5107):483. - PubMed
    1. Marshall E. Lobbyists seek to reslice NIH's pie. Science. 1997;276(5311):344–6. doi: 10.1126/science.276.5311.344. - DOI - PubMed
    1. National Institutes of Health Working Group on Priority Setting. Setting research priorities at the National Institutes of Health. Bethesda, MD: National Institutes of Health; 1997.
    1. Committee on NIH Research Priority-Setting Process. Scientific opportunities and public needs: Improving priority setting and public input at the national institutes of health. 1998. - PubMed

LinkOut - more resources